The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in
critically ill patients and is defined by the acute onset of noncardiogenic pulmonary oedema …

Introduction Pulmonary vascular dysfunction, pulmonary hypertension (PH), and resulting
right ventricular (RV) failure occur in many critical illnesses and may be associated with a …

Acute lung injury (ALI) and its most severe extreme the acute respiratory distress syndrome
(ARDS) refer to increased-permeability pulmonary edema caused by a variety of pulmonary …

IN 1998, the World Health Organization sponsored a symposium on pulmonary
hypertension at which a new, more clinically useful classification system was adopted. § …

OBJECTIVE This study aimed to determine whether inhaled prostaglandins are associated
with improvement in pulmonary physiology or mortality in patients with ARDS and assess …

Acute lung injury (ALI) and acute respiratory distress syndrome are characterized by protein
rich alveolar edema, reduced lung compliance, and acute severe hypoxemia. A degree of …

BACKGROUND: The purpose of this study was to describe our institutional experience in
using inhaled prostacyclin as a selective pulmonary vasodilator in patients with pulmonary …

Severe acute respiratory syndrome (SARS) is characterized by acute respiratory distress
syndrome (ARDS) and pulmonary fibrosis, and monocytes/macrophages are the key players …

ARDS is characterized by hypoxemic respiratory failure, which can be refractory and life-
threatening. Modifications to traditional mechanical ventilation and nontraditional modes of …

Background: Inhaled pulmonary vasodilators are used as adjunctive therapies for the
treatment of refractory hypoxemia. Available evidence suggest they improve oxygenation in …